Response Genetics, Inc.盘中异触动 股价父亲上涨150.
作者:cmsbuy来源:cmsbuy.cn时间:2019-06-28

  北边京时间2019年05月17日01时41分,Response Genetics, Inc.(RGDXQ.us)股票出产即兴异触动,股价快快弹奏升150.00%。截到发稿,该股报0.005美元/股,成提交量28.2739万股,换顺手比值0.73%,振幅135.80%。

  最新的2015-06-30数据露示,该股完成营业顶出产3.82佰万美元,净盈利-4.83佰万美元,每股进款-0.12美元,厚利1.91佰万美元,市载比值0.00倍。

  机构评级方面,当前暂无机构对该股做出产“买进入、持拥有、减持、卖出产”建议。

  Response Genetics, Inc.股票所在的生命迷信行业中,所拥有上涨幅为1.44%。其相干个股中,Trinity Biotech Plc、T2 Biosystems Inc、Palatin Technologies Inc上涨幅较父亲,Precipio Inc、Endra Life Sciences Inc、基因技术ADR较为生触动,换顺手比值区别为8.19%、3.24%、3.18%,振幅较父亲的相干个股拥有Endra Life Sciences Inc、Fulgent Genetics Inc、Trinity Biotech Plc,振幅区别为18.30%、12.75%、11.30%。

  Response Genetics, Inc.公司信介:Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.

  (以上情节为己选股智能机具写顺手Money Call完成,但干为用户看盘参考,不干为买进卖根据。)

热门推荐

随机推荐
  • 威廉希尔娱乐:共享充电
  • 按捺城市募化本钱,才干
  • “苦夏季”喝此雕刻些柯
本站为澳门金沙线上娱乐官网,所有信息和图片来自网络,不代表本站观点!